Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression

Interleukin-6 (IL-6) is a key pathogenic cytokine in multiple autoimmune diseases including rheumatoid arthritis and multiple sclerosis, suggesting that dysregulation of the IL-6 pathway may be a common feature of autoimmunity. The role of IL-6 in type 1 diabetes (T1D) is not well understood. We sho...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Transl Med
Egile Nagusiak: Hundhausen, Christian, Roth, Alena, Whalen, Elizabeth, Chen, Janice, Schneider, Anya, Long, S. Alice, Wei, Shan, Rawlings, Rebecca, Kinsman, MacKenzie, Evanko, Stephen P., Wight, Thomas N., Greenbaum, Carla J., Cerosaletti, Karen, Buckner, Jane H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5125295/
https://ncbi.nlm.nih.gov/pubmed/27629486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aad9943
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak